Fractyl Health, Inc.
GUTS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001572616
In the last 90 days, Fractyl Health, Inc. insiders filed 1 open-market purchase and 0 sales; 77 institutions reported holding it in 13F filings for Q2 2026, worth $56.2M in total; Maverick Capital is the only superinvestor holding it.
Q4 2025 vs. Q3 2025
How the institutions holding Fractyl Health, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 74 | 2 | 97 | +25 |
| Shares | 91.5M | 14.6K | 112.4M | +20.9M (+22.9%) |
| Value | $145.4M | $23.1K | $247.3M | +$101.9M (+70.1%) |
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (33)
Institutions that held Fractyl Health, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (8)
Institutions that held Fractyl Health, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Alphabet Inc. | 662,584 | $1.05M |
| HRT Financial LP | 614,792 | $977.0K |
| Arrowpoint Investment Partners (Singapore) Pte. Ltd. | 35,000 | $55.6K |
| Stoneridge Investment Partners LLC | 23,721 | $38.0K |
| ADAR1 Capital Management, LLC | 13,097 | $20.8K |
| EverSource Wealth Advisors, LLC | 39 | $62 |
| Royal Bank of Canada | 196 | $0 |
| CWM, LLC | 149 | $0 |
Not filed for Q4 2025 yet (2)
Institutions that held Fractyl Health, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Point72 Asia (Singapore) Pte. Ltd. | 14,126 | $22.5K |
| Point72 (DIFC) Ltd | 430 | $683 |